Long-term Tamoxifen Use Increases The Risk Of ER Negative Second Breast Cancer

[News]

While long-term tamoxifen use among breast cancer survivors decreases their risk of developing the most common, less aggressive type of second breast cancer, such use is associated with a more than four-fold increased risk of a more aggressive, difficult-to-treat type of cancer in the breast opposite, or contralateral, to the initial tumor. These findings by Christopher Li, M.D., Ph.D., and colleagues at Fred Hutchinson Cancer Research Center were published online Aug.

More... (http://www.medicalnewstoday.com/articles/161850.php)